๐Ÿงช Beta โ€” BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

ct vs cyc

Mechanistic comparison of ct 7001 and cyc 065 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

4
Shared Targets
50%
Jaccard Similarity
48%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

ct 7001
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’
cyc 065
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’

Target Overlap

ct and cyc share 4 molecular targets based on binding affinity data from BindingDB (Kd/IC50 โ‰ค 10 ยตM) and ChEMBL. A Jaccard index of 0.500 means 50% of the combined target set is bound by both compounds. The IDF-weighted score of 0.478 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do ct and cyc have in common?
ct and cyc share 4 molecular targets with a Jaccard similarity of 50%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can ct and cyc be combined?
ct and cyc share 4 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: ct or cyc?
In the BiohacksAI corpus: ct has 0 PubMed-indexed studies, cyc has 0 studies.

Related Comparisons

Similar to ct

ct vs voruciclib7 targetsct vs s5 targetsct vs roniciclib5 targetsct vs ebvaciclib4 targetsct vs zemirciclib6 targets

Similar to cyc

cyc vs s4 targetscyc vs meriolin2 targetscyc vs roniciclib3 targetscyc vs voruciclib3 targetscyc vs istisociclib2 targets
View full ct profile โ†’View full cyc profile โ†’Browse all substances โ†’